Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Dartmouth College | OTHER |
| Patient-Centered Outcomes Research Institute | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Fifteen minutes is the typical length of an outpatient medication management appointment for people with serious mental health conditions. These brief interactions with prescribers are frequently provider-driven with insufficient time focused on the patient's needs and personal recovery. Shared decision making is a strategy that could improve this interaction. This study examines how technology can be used in the care process to amplify the voice of the patient, support shared decisions, and improve treatment outcomes.
Investigators will compare the effectiveness of Measurement-Based vs. Person-Centered Care on two primary patient-centered outcomes: the patient experience of care with medication treatment and the level of shared decision making. Investigators hypothesize that:
The study team will collect information from patients, caregivers, and clinic staff at different points in time during the study. Patients will be asked to complete questionnaires, and additional data on their service use will be gathered. Some patients and providers will also be interviewed about their experiences with care. Investigators are especially interested to learn if and how these two approaches are perceived to change medication treatment, if patients are more satisfied and empowered in their care, and why and how providers perceive and adopt changes to their clinical care.
An important attribute of patient-centered care is the active engagement of patients in making health care decisions. Despite advances in health care to support shared decision making, the patient experience of mental health care remains provider-driven. For individuals with serious mental illness (SMI), important decisions involve the choice of medications and how best to use medications to support individualized, person-centered recovery goals. By comparing the effectiveness of two approaches for promoting shared decision making around medication treatment on outcomes that matter most to individuals with SMI, the proposed study will advance ongoing and much-needed efforts to evolve toward a more personalized, recovery-oriented system of mental health care.
Building on the work of a multi-stakeholder collaboration, investigators will compare two interventions, Person-Centered Care and Measurement-Based Care, both focused on patient-prescriber interactions around medication treatment. The investigators' study will address three questions that patients have identified as important to them:
Study aims will compare the effectiveness of measurement-based vs. person-centered care on the patient experience of care and on shared decision making. Investigators hypothesize that:
In addition, investigators will compare the effectiveness of the two approaches on seven secondary patient-centered outcomes, and examine differences in outcomes within the two approaches for subgroups of patients based on their: (1) current status regarding psychiatric medication, (2) engagement with the interventions, and (3) illness severity.
The target population is 2,460+ Medicaid-enrolled adults with SMI who receive medication treatment at one of 15 community mental health centers (CMHC). Using a prospective cluster-randomized design with a mixed-methods approach, investigators will randomly assign CMHCs to one of the two interventions. Quantitative (self-report, claims, process) and qualitative (interviews) data will be gathered at multiple time points across the two-year intervention period (baseline, 8 months, 16 months, and 24 months). Multi-level longitudinal analyses will examine the impact of the interventions on outcomes and explore the role of moderating variables. Qualitative data will be used to understand patient and stakeholder perspectives and to promote dissemination and sustainability.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Person-Centered Care | Active Comparator | Decision support center staffed by peers. Patient uses the CommonGround program prior to medication visit to prepare a personal report, with support from peer(s). The CommonGround report expresses goals for medication, how other strategies help with functioning, current problems, and medication side effects. Patient brings report into the medication visit. Prescriber and patient discuss medication options, and prescriber enters the shared decision into CommonGround during the visit. |
|
| Measurement-Based Care | Active Comparator | Clinic staff asks each patient to use a tablet computer to complete a brief assessment of symptoms and problems prior to medication visit. Prescriber views assessment results on office computer and discusses next steps in medication management with the patient. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Person-Centered Care | Behavioral | Decision support center staffed by peers. Patient uses the CommonGround program prior to medication visit to prepare a personal report, with support from peer(s). The CommonGround report expresses goals for medication, how other strategies help with functioning, current problems, and medication side effects. Patient brings report into the medication visit. Prescriber and patient discuss medication options, and prescriber enters the shared decision into CommonGround during the visit. |
| Measure | Description | Time Frame |
|---|---|---|
| Patient Experience of Medication Treatment (PEMM) | The PEMM is a 12-item self-report measure of mental health patient experience of medication management with prescribers .Response options for 11 questions range from 0=Never to 4=Always, and the response options for the final question range from 0=Very Dissatisfied to 4=Very Satisfied. Overall possible range was 0 to 4. PEMM scores for each time point reflect the mean score of all measures collected within that time frame. | Baseline and every eight months during the two-year intervention phase |
| Shared Decision Making Questionnaire (SDM-Q-9) | The SDM-Q-9 is a 9-item self-report measure of the degree of shared decision making in clinical encounters. There are 6 possible responses ranging from: Completely Disagree (0) to Completely Agree (5). Raw score ranges from 0 to 45. Multiplication of the raw score by 20/9 provides a score forced (transformed) to range from 0 to 100, where 0 indicates the lowest possible level of SDM and 100 indicates the highest extent of shared decision making in clinical encounters. SDM-Q-9 scores for each time point reflect the mean score of all measures collected within that time frame. | Baseline and every eight months during the two-year intervention phase |
| Measure | Description | Time Frame |
|---|---|---|
| Hope | Patient hopefulness will be assessed using a single question: "Overall, how hopeful does the patient feel about his/her life?" Responses are on a scale of 1 through 10 with 1=No Hope and 10=Filled with Hope. Hopefulness scores for each time point reflect the mean score of all measures collected within that time frame. | Baseline and every eight months during the two-year intervention phase |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Gregory J McHugo, PhD | Dartmouth Psychiatric Research Center, The Geisel School of Medicine at Dartmouth | Principal Investigator |
| Kim MacDonald-Wilson, ScD,CRC,CPRP | UPMC Center for High-Value Health Care | Principal Investigator |
| Patricia E Deegan, PhD | Pat Deegan, PhD & Associates, LLC | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Dartmouth Psychiatric Research Center | Lebanon | New Hampshire | 03766 | United States | ||
| UPMC Center for High-Value Health Care |
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Person-Centered Care | Decision support center staffed by peers. Patient uses the CommonGround program prior to medication visit to prepare a personal report, with support from peer(s). The CommonGround report expresses goals for medication, how other strategies help with functioning, current problems, and medication side effects. Patient brings report into the medication visit. Prescriber and patient discuss medication options, and prescriber enters the shared decision into CommonGround during the visit. Person-Centered Care: Decision support center staffed by peers. Patient uses the CommonGround program prior to medication visit to prepare a personal report, with support from peer(s). The CommonGround report expresses goals for medication, how other strategies help with functioning, current problems, and medication side effects. Patient brings report into the medication visit. Prescriber and patient discuss medication options, and prescriber enters the shared decision into CommonGround during the visi |
| FG001 | Measurement-Based Care | Clinic staff asks each patient to use a tablet computer to complete a brief assessment of symptoms and problems prior to medication visit. Prescriber views assessment results on office computer and discusses next steps in medication management with the patient. Measurement-Based Care: Clinic staff asks each patient to use a tablet computer to complete a brief assessment of symptoms and problems prior to medication visit. Prescriber views assessment results on office computer and discusses next steps in medication management with the patient. |
| Title | Milestones | Reasons Not Completed | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
The analysis population is different from the assignment in the Participant Flow because participants were only included in analysis if they had a baseline survey record (i.e., not all who consented completed baseline questionnaires).
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Person-Centered Care | Decision support center staffed by peers. Patient uses the CommonGround program prior to medication visit to prepare a personal report, with support from peer(s). The CommonGround report expresses goals for medication, how other strategies help with functioning, current problems, and medication side effects. Patient brings report into the medication visit. Prescriber and patient discuss medication options, and prescriber enters the shared decision into CommonGround during the visit. Person-Centered Care: Decision support center staffed by peers. Patient uses the CommonGround program prior to medication visit to prepare a personal report, with support from peer(s). The CommonGround report expresses goals for medication, how other strategies help with functioning, current problems, and medication side effects. Patient brings report into the medication visit. Prescriber and patient discuss medication options, and prescriber enters the shared decision into CommonGround during the visi |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Patient Experience of Medication Treatment (PEMM) | The PEMM is a 12-item self-report measure of mental health patient experience of medication management with prescribers .Response options for 11 questions range from 0=Never to 4=Always, and the response options for the final question range from 0=Very Dissatisfied to 4=Very Satisfied. Overall possible range was 0 to 4. PEMM scores for each time point reflect the mean score of all measures collected within that time frame. | Multiple records can be measured from the same participant at the same time period, so overall number of surveys analyzed can be greater than the unique number of participants except for at baseline. | Posted | Mean | Standard Deviation | Units on a scale | Baseline and every eight months during the two-year intervention phase | Survey Records | Survey Records |
|
Over the 24-month intervention period.
This is a behavioral intervention that did not involve "Serious" and "Other" adverse events, hence the reason none are reported.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Person-Centered Care | Decision support center staffed by peers. Patient uses the CommonGround program prior to medication visit to prepare a personal report, with support from peer(s). The CommonGround report expresses goals for medication, how other strategies help with functioning, current problems, and medication side effects. Patient brings report into the medication visit. Prescriber and patient discuss medication options, and prescriber enters the shared decision into CommonGround during the visit. Person-Centered Care: Decision support center staffed by peers. Patient uses the CommonGround program prior to medication visit to prepare a personal report, with support from peer(s). The CommonGround report expresses goals for medication, how other strategies help with functioning, current problems, and medication side effects. Patient brings report into the medication visit. Prescriber and patient discuss medication options, and prescriber enters the shared decision into CommonGround during the visit. |
Not provided
Not provided
The PEMM was developed for this study. For unavoidable reasons, site randomization was not maintained. Data collection timepoints were expanded.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Kelly Williams, Program Administrator | UPMC Center for High-Value Health Care | 412-454-1198 | Williamsk17@upmc.edu |
Not provided
| ID | Term |
|---|---|
| D012559 | Schizophrenia |
| D001714 | Bipolar Disorder |
| D003865 | Depressive Disorder, Major |
| ID | Term |
|---|---|
| D019967 | Schizophrenia Spectrum and Other Psychotic Disorders |
| D001523 | Mental Disorders |
| D000068105 | Bipolar and Related Disorders |
| D019964 | Mood Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D018802 | Patient-Centered Care |
| ID | Term |
|---|---|
| D011320 | Primary Health Care |
| D003191 | Comprehensive Health Care |
| D010346 | Patient Care Management |
| D006298 | Health Services Administration |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Measurement-Based Care | Behavioral | Clinic staff asks each patient to use a tablet computer to complete a brief assessment of symptoms and problems prior to medication visit. Prescriber views assessment results on office computer and discusses next steps in medication management with the patient. |
|
| Medication Side Effects | Medication side effects will be assessed using a single question: "How much is the patient troubled by medication side effects?" Responses are on a scale of 1 through 10 with 1=Not Bothered at all by side effects and 10=Very Bothered by side effects. Medication side effect scores for each time point reflect the mean score of all measures collected within that time frame. | Baseline and every eight months during the two-year intervention phase |
| Patient Activation Measure (PAM) | PAM is a 13-item scale that assesses the knowledge, skills, and confidence of patients essential to managing their own health and health care. Response options are: Strongly Disagree, Disagree, Agree, and Strongly Agree. The activation scale for the PAM ranges from 0 to 100. The lower values represent a poor outcome while higher values represent a better outcome. Overall possible range was 0 to 91.6. PAM scores for each time point reflect the mean score of all measures collected within that time frame. | Baseline and every eight months during the two-year intervention phase |
| Behavior and Symptom Identification Scale (BASIS-24) | The BASIS-24 identifies a wide range of symptoms and problems that occur across the psychiatric diagnostic spectrum. There are 5 ordered responses either ranging from No Difficulty to Extreme Difficulty or from None of the Time to All of the Time. Each of 24 questions is scored on a 5 point scale (from 0 to 4 where 0 is the lowest severity and 4 is the highest). The overall BASIS-24 score is a weighted sum that is computed by multiplying the rating for each question by its weight and totaling the weighted ratings for each question. Overall possible range was 0 to 3.99. BASIS-24 scores for each time point reflect the mean score of all measures collected within that time frame. | Baseline and every eight months during the two-year intervention phase |
| Sheehan Disability Scale | The Sheehan Disability Scale measures the extent to which three major sectors in the person's life are impaired by psychiatric symptoms (work/school, social/leisure life, and family/home life). The 3 items are summed together to form a single measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). Sheehan Disability Scale scores for each time point reflect the mean score of all measures collected within that time frame. | Baseline and every eight months during the two-year intervention phase |
| Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form (QLESQ-SF) | Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form is a 16-item, self-report questionnaire for assessing quality of life in multiple domains (e.g., physical health, mood, leisure time activities, social relationships, and overall). Response items are on a 5-point scale ranging from Very Poor to Very Good. The scoring of the Q-LES-Q-SF involves summing only the first 14 items to yield a raw total score. The last two items are not included in the total score but are standalone items. The raw total score ranges from 14 to 70. The raw total score was transformed into a percentage maximum possible score using the following formula. The lower values/percentages represent a poor outcome while higher values/percentages represent a better outcome. Overall possible range was 0-100. QLESQ-SF scores for each time point reflect the mean score of all measures collected within that time frame. | Baseline and every eight months during the two-year intervention phase |
| Engagement in Medication and Evaluation Visit | Count of the number of medication checks and evaluation visits for each study participant for the 12 month period prior to and including the anchor date of the time point. | Baseline, 8 months, 24 months |
| Engagement in Psychotherapy Visit | Count of the number of psychotherapy visits for each study participant for the 12 month period prior to and including the anchor date of the time point. | Baseline, 8 months, 24 months |
| Pittsburgh |
| Pennsylvania |
| 15219 |
| United States |
| Lost to Follow-up |
|
| BG001 | Measurement-Based Care | Clinic staff asks each patient to use a tablet computer to complete a brief assessment of symptoms and problems prior to medication visit. Prescriber views assessment results on office computer and discusses next steps in medication management with the patient. Measurement-Based Care: Clinic staff asks each patient to use a tablet computer to complete a brief assessment of symptoms and problems prior to medication visit. Prescriber views assessment results on office computer and discusses next steps in medication management with the patient. |
| BG002 | Total | Total of all reporting groups |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Ethnicity (NIH/OMB) | Count of Participants | Participants |
|
| Race/Ethnicity, Customized | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
| OG001 | Measurement-Based Care | Clinic staff asks each patient to use a tablet computer to complete a brief assessment of symptoms and problems prior to medication visit. Prescriber views assessment results on office computer and discusses next steps in medication management with the patient. Measurement-Based Care: Clinic staff asks each patient to use a tablet computer to complete a brief assessment of symptoms and problems prior to medication visit. Prescriber views assessment results on office computer and discusses next steps in medication management with the patient. |
|
|
|
| Primary | Shared Decision Making Questionnaire (SDM-Q-9) | The SDM-Q-9 is a 9-item self-report measure of the degree of shared decision making in clinical encounters. There are 6 possible responses ranging from: Completely Disagree (0) to Completely Agree (5). Raw score ranges from 0 to 45. Multiplication of the raw score by 20/9 provides a score forced (transformed) to range from 0 to 100, where 0 indicates the lowest possible level of SDM and 100 indicates the highest extent of shared decision making in clinical encounters. SDM-Q-9 scores for each time point reflect the mean score of all measures collected within that time frame. | Multiple records can be measured from the same participant at the same time period, so N can be greater than the unique number of participants except for the baseline | Posted | Mean | Standard Deviation | Units on a scale | Baseline and every eight months during the two-year intervention phase | Survey Records | Survey Records |
|
|
|
|
| Secondary | Hope | Patient hopefulness will be assessed using a single question: "Overall, how hopeful does the patient feel about his/her life?" Responses are on a scale of 1 through 10 with 1=No Hope and 10=Filled with Hope. Hopefulness scores for each time point reflect the mean score of all measures collected within that time frame. | Multiple records can be measured from the same participant at the same time period, so N can be greater than the unique number of participants except for the baseline | Posted | Mean | Standard Deviation | Units on a scale | Baseline and every eight months during the two-year intervention phase | Survey Records | Survey Records |
|
|
|
|
| Secondary | Medication Side Effects | Medication side effects will be assessed using a single question: "How much is the patient troubled by medication side effects?" Responses are on a scale of 1 through 10 with 1=Not Bothered at all by side effects and 10=Very Bothered by side effects. Medication side effect scores for each time point reflect the mean score of all measures collected within that time frame. | Multiple records can be measured from the same participant at the same time period, so N can be greater than the unique number of participants except for the baseline | Posted | Mean | Standard Deviation | Units on a scale | Baseline and every eight months during the two-year intervention phase | Survey Records | Survey Records |
|
|
|
|
| Secondary | Patient Activation Measure (PAM) | PAM is a 13-item scale that assesses the knowledge, skills, and confidence of patients essential to managing their own health and health care. Response options are: Strongly Disagree, Disagree, Agree, and Strongly Agree. The activation scale for the PAM ranges from 0 to 100. The lower values represent a poor outcome while higher values represent a better outcome. Overall possible range was 0 to 91.6. PAM scores for each time point reflect the mean score of all measures collected within that time frame. | Multiple records can be measured from the same participant at the same time period, so N can be greater than the unique number of participants except for the baseline | Posted | Mean | Standard Deviation | Units on a scale | Baseline and every eight months during the two-year intervention phase | Survey Records | Survey Records |
|
|
|
|
| Secondary | Behavior and Symptom Identification Scale (BASIS-24) | The BASIS-24 identifies a wide range of symptoms and problems that occur across the psychiatric diagnostic spectrum. There are 5 ordered responses either ranging from No Difficulty to Extreme Difficulty or from None of the Time to All of the Time. Each of 24 questions is scored on a 5 point scale (from 0 to 4 where 0 is the lowest severity and 4 is the highest). The overall BASIS-24 score is a weighted sum that is computed by multiplying the rating for each question by its weight and totaling the weighted ratings for each question. Overall possible range was 0 to 3.99. BASIS-24 scores for each time point reflect the mean score of all measures collected within that time frame. | Multiple records can be measured from the same participant at the same time period, so N can be greater than the unique number of participants except for the baseline | Posted | Mean | Standard Deviation | Units on a scale | Baseline and every eight months during the two-year intervention phase | Survey Records | Survey Records |
|
|
|
|
| Secondary | Sheehan Disability Scale | The Sheehan Disability Scale measures the extent to which three major sectors in the person's life are impaired by psychiatric symptoms (work/school, social/leisure life, and family/home life). The 3 items are summed together to form a single measure of global functional impairment that ranges from 0 (unimpaired) to 30 (highly impaired). Sheehan Disability Scale scores for each time point reflect the mean score of all measures collected within that time frame. | Multiple records can be measured from the same participant at the same time period, so N can be greater than the unique number of participants except for the baseline | Posted | Mean | Standard Deviation | Units on a scale | Baseline and every eight months during the two-year intervention phase | Survey Records | Survey Records |
|
|
|
|
| Secondary | Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form (QLESQ-SF) | Quality of Life Enjoyment and Satisfaction Questionnaire - Short Form is a 16-item, self-report questionnaire for assessing quality of life in multiple domains (e.g., physical health, mood, leisure time activities, social relationships, and overall). Response items are on a 5-point scale ranging from Very Poor to Very Good. The scoring of the Q-LES-Q-SF involves summing only the first 14 items to yield a raw total score. The last two items are not included in the total score but are standalone items. The raw total score ranges from 14 to 70. The raw total score was transformed into a percentage maximum possible score using the following formula. The lower values/percentages represent a poor outcome while higher values/percentages represent a better outcome. Overall possible range was 0-100. QLESQ-SF scores for each time point reflect the mean score of all measures collected within that time frame. | Multiple records can be measured from the same participant at the same time period, so N can be greater than the unique number of participants except for the baseline | Posted | Mean | Standard Deviation | Units on a scale | Baseline and every eight months during the two-year intervention phase | Survey Records | Survey Records |
|
|
|
|
| Secondary | Engagement in Medication and Evaluation Visit | Count of the number of medication checks and evaluation visits for each study participant for the 12 month period prior to and including the anchor date of the time point. | Based on participants who had available claims data. | Posted | Mean | Standard Deviation | medication checks and evaluation visits | Baseline, 8 months, 24 months |
|
|
|
|
| Secondary | Engagement in Psychotherapy Visit | Count of the number of psychotherapy visits for each study participant for the 12 month period prior to and including the anchor date of the time point. | Based on participants who had available claims data. | Posted | Mean | Standard Deviation | psychotherapy visits | Baseline, 8 months, 24 months |
|
|
|
|
| 12 |
| 1,232 |
| 0 |
| 1,232 |
| 0 |
| 1,232 |
| EG001 | Measurement-Based Care | Clinic staff asks each patient to use a tablet computer to complete a brief assessment of symptoms and problems prior to medication visit. Prescriber views assessment results on office computer and discusses next steps in medication management with the patient. Measurement-Based Care: Clinic staff asks each patient to use a tablet computer to complete a brief assessment of symptoms and problems prior to medication visit. Prescriber views assessment results on office computer and discusses next steps in medication management with the patient. | 16 | 1,211 | 0 | 1,211 | 0 | 1,211 |
Not provided
Not provided
| D003866 | Depressive Disorder |
|
|
|
|
|
|
|
|
|
| Month 3: Every record 0< month <=3 |
|
|
| Month 6: Every record 3< month <=6 |
|
|
| Month 8: Every record 6< month <=8 |
|
|
| Month 12: Every record 8< month <=12 |
|
|
| Month16: Every record 12< month <=16 |
|
|
| Month 18: Every record 16< month <=18 |
|
|
| Month 20: Every record 18< month <=20 |
|
|
| Month 24: Every record 20< month |
|
|
| 0.1969 |
| Superiority |
| Three-way interaction effect (treatment, polynomial time, and age group 1) where age group 1 is defined by 0 (reference) if <=35; 1 if (35<age<=49); 2 if age >49 | Mixed Models Analysis | 0.0042 | Superiority |
| Three-way interaction effect (treatment, polynomial time, and SMI group). Participants with a diagnosis of major depression, schizoaffective or schizophrenia were classified into the SMI group and the reference group (Non-SMI) included diagnosis of anxiety, PTSD, depression/dysthymia/depression nos. | Mixed Models Analysis | 0.0002 | Superiority |
| Three-way interaction effect of time, treatment, and the basis subgroups (no symptoms =group 1; at least 1 severe symptom = group 2) | Mixed Models Analysis | 0.7254 | Superiority |
| Three-way interaction of Treatment, time, and subgroup of side effects. Subgroup of side effect= 0 if the response to the medication side effects question at baseline is 1, 2, or 3 (i.e. subgroup of participants who are minimally bothered by medication side effects at baseline); Subgroup of side effect= 1 if the response to the medication side effects question at baseline is 4-10 (i.e. subgroup of participants who are moderately or very bothered by medication side effects at baseline) | Mixed Models Analysis | 0.0580 | Superiority |
|
| Month 3: Every record 0< month <=3 |
|
|
| Month 6: Every record 3< month <=6 |
|
|
| Month 8: Every record 6< month <=8 |
|
|
| Month 12: Every record 8< month <=12 |
|
|
| Month16: Every record 12< month <=16 |
|
|
| Month 18: Every record 16< month <=18 |
|
|
| Month 20: Every record 18< month <=20 |
|
|
| Month 24: Every record 20< month |
|
|
| 0.0940 |
| Superiority |
|
| Month 3: Every record 0< month <=3 |
|
|
| Month 6: Every record 3< month <=6 |
|
|
| Month 8: Every record 6< month <=8 |
|
|
| Month 12: Every record 8< month <=12 |
|
|
| Month16: Every record 12< month <=16 |
|
|
| Month 18: Every record 16< month <=18 |
|
|
| Month 20: Every record 18< month <=20 |
|
|
| Month 24: Every record 20< month |
|
|
| 0.0113 |
| Superiority |
|
| Month 3: Every record 0< month <=3 |
|
|
| Month 6: Every record 3< month <=6 |
|
|
| Month 8: Every record 6< month <=8 |
|
|
| Month 12: Every record 8< month <=12 |
|
|
| Month16: Every record 12< month <=16 |
|
|
| Month 18: Every record 16< month <=18 |
|
|
| Month 20: Every record 18< month <=20 |
|
|
| Month 24: Every record 20< month |
|
|
| 0.0005 |
| Superiority |
|
| Month 3: Every record 0< month <=3 |
|
|
| Month 6: Every record 3< month <=6 |
|
|
| Month 8: Every record 6< month <=8 |
|
|
| Month 12: Every record 8< month <=12 |
|
|
| Month16: Every record 12< month <=16 |
|
|
| Month 18: Every record 16< month <=18 |
|
|
| Month 20: Every record 18< month <=20 |
|
|
| Month 24: Every record 20< month |
|
|
|
| Month 3: Every record 0< month <=3 |
|
|
| Month 6: Every record 3< month <=6 |
|
|
| Month 8: Every record 6< month <=8 |
|
|
| Month 12: Every record 8< month <=12 |
|
|
| Month16: Every record 12< month <=16 |
|
|
| Month 18: Every record 16< month <=18 |
|
|
| Month 20: Every record 18< month <=20 |
|
|
| Month 24: Every record 20< month |
|
|
| 0.0016 |
| Superiority |
|
| Month 3: Every record 0< month <=3 |
|
|
| Month 6: Every record 3< month <=6 |
|
|
| Month 8: Every record 6< month <=8 |
|
|
| Month 12: Every record 8< month <=12 |
|
|
| Month16: Every record 12< month <=16 |
|
|
| Month 18: Every record 16< month <=18 |
|
|
| Month 20: Every record 18< month <=20 |
|
|
| Month 24: Every record 20< month |
|
|
| 8 months |
|
|
| 24 months |
|
|
| 8 months |
|
|
| 24 months |
|
|